1
|
Blanco-Paniagua E, Álvarez-Fernández L, Millán-García A, Rivas G, Álvarez AI, Merino G. Coadministration of ivermectin and abamectin affects milk pharmacokinetics of the antiparasitic clorsulon in Assaf sheep. Front Vet Sci 2023; 10:1268658. [PMID: 37929285 PMCID: PMC10622746 DOI: 10.3389/fvets.2023.1268658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Accepted: 10/05/2023] [Indexed: 11/07/2023] Open
Abstract
In veterinary field, drug exposure during milk production in dairy cattle is considered a major health problem which concerns dairy consumers. The induced expression of the ABC transporter G2 (ABCG2) in the mammary gland during lactation plays a significant role in the active secretion of many compounds into milk. The main objective of this study was to determine the involvement of ABCG2 in the secretion into milk of the antiparasitic clorsulon in sheep as well as the possible effect of the coadministration of model ABCG2 inhibitors such as macrocyclic lactones on this process. Cells transduced with the ovine variant of ABCG2 were used to carry out in vitro transepithelial transport assays in which we showed that clorsulon is a substrate of the ovine transporter. In addition, ivermectin and abamectin significantly inhibited clorsulon transport mediated by ovine ABCG2. In vivo interactions were studied in Assaf sheep after coadministration of clorsulon (in DMSO, 2 mg/kg, s.c.) with ivermectin (Ivomec®, 0.2 mg/kg, s.c.) or abamectin (in DMSO, 0.2 mg/kg, s.c.). After ivermectin and abamectin treatment, no relevant statistically significant differences in plasma levels of clorsulon were reported between the experimental groups since there were no differences in the area under the plasma concentration-curve (AUC) between clorsulon treatment alone and coadministration with macrocyclic lactones. With regard to milk, total amount of clorsulon, as percentage of dose excreted, did not show statistically significant differences when macrocyclic lactones were coadministered. However, the AUC for clorsulon significantly decreased (p < 0.05) after coadministration with ivermectin (15.15 ± 3.17 μg h/mL) and abamectin (15.30 ± 3.25 μg h/mL) compared to control group (20.73 ± 4.97 μg h/mL). Moreover, milk parameters such as half-life (T1/2) and mean residence time (MRT) were significantly lower (p < 0.05) after coadministration of macrocyclic lactones. This research shows that the milk pharmacokinetics of clorsulon is affected by the coadministration of ABCG2 inhibitors, reducing drug persistence in milk.
Collapse
Affiliation(s)
- Esther Blanco-Paniagua
- Department of Biomedical Sciences-Physiology, Faculty of Veterinary, University of León, León, Spain
- Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), University of León, León, Spain
| | - Laura Álvarez-Fernández
- Department of Biomedical Sciences-Physiology, Faculty of Veterinary, University of León, León, Spain
- Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), University of León, León, Spain
| | - Alicia Millán-García
- Department of Biomedical Sciences-Physiology, Faculty of Veterinary, University of León, León, Spain
- Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), University of León, León, Spain
| | - Guillermo Rivas
- Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), University of León, León, Spain
| | - Ana I. Álvarez
- Department of Biomedical Sciences-Physiology, Faculty of Veterinary, University of León, León, Spain
- Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), University of León, León, Spain
| | - Gracia Merino
- Department of Biomedical Sciences-Physiology, Faculty of Veterinary, University of León, León, Spain
- Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), University of León, León, Spain
| |
Collapse
|
2
|
Blanco-Paniagua E, Garcia-Lino AM, Alvarez-Fernández L, Alvarez AI, Merino G. Ivermectin inhibits ovine ABCG2-mediated in vitro transport of meloxicam and reduces its secretion into milk in sheep. Res Vet Sci 2022; 153:88-91. [PMID: 36327623 DOI: 10.1016/j.rvsc.2022.10.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2022] [Revised: 10/07/2022] [Accepted: 10/14/2022] [Indexed: 11/06/2022]
Abstract
The ATP-binding cassette transporter G2 (ABCG2) is an efflux protein involved in the bioavailability and secretion into milk of several compounds including anti-inflammatory drugs. The aim of this work was to determine the effect in sheep of an ABCG2 inhibitor, such as the macrocyclic lactone ivermectin, on the secretion into milk of meloxicam, a non-steroidal anti-inflammatory drug widely used in veterinary medicine, and recently reported as an ABCG2 substrate. In vitro meloxicam transport assays in ovine ABCG2-transduced cells have shown that ivermectin is an efficient inhibitor of in vitro transport of meloxicam mediated by ovine ABCG2, with a 75% inhibition in the transport ratio (24.85 ± 4.62 in controls vs 6.31 ± 1.37 in presence of ivermectin). In addition, the role of ovine ABCG2 in secretion into milk of meloxicam was corroborated using Assaf lactating sheep coadministered with ivermectin. Animals were administered subcutaneously with meloxicam (0.5 mg/kg) with or without ivermectin (0.2 mg/kg). No difference in plasma pharmacokinetic parameters was found between treatments. In the case of milk, a significant reduction in the area under concentration-time curve (AUC) (3.92 ± 0.66 vs 2.26 ± 1.52 μg·h/mL) and the AUC milk-to-plasma ratio (0.17 ± 0.03 vs 0.09 ± 0.06) was reported for ivermectin-treated animals compared to controls.
Collapse
Affiliation(s)
- Esther Blanco-Paniagua
- Departmento de Ciencias Biomédicas-Fisiología, Facultad de Veterinaria, University of León, Campus de Vegazana s/n, 24071 León, Spain; Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), University of León, Campus de Vegazana, 24071 León, Spain
| | - Alba M Garcia-Lino
- Departmento de Ciencias Biomédicas-Fisiología, Facultad de Veterinaria, University of León, Campus de Vegazana s/n, 24071 León, Spain; Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), University of León, Campus de Vegazana, 24071 León, Spain
| | - Laura Alvarez-Fernández
- Departmento de Ciencias Biomédicas-Fisiología, Facultad de Veterinaria, University of León, Campus de Vegazana s/n, 24071 León, Spain; Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), University of León, Campus de Vegazana, 24071 León, Spain
| | - Ana I Alvarez
- Departmento de Ciencias Biomédicas-Fisiología, Facultad de Veterinaria, University of León, Campus de Vegazana s/n, 24071 León, Spain; Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), University of León, Campus de Vegazana, 24071 León, Spain
| | - Gracia Merino
- Departmento de Ciencias Biomédicas-Fisiología, Facultad de Veterinaria, University of León, Campus de Vegazana s/n, 24071 León, Spain; Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), University of León, Campus de Vegazana, 24071 León, Spain.
| |
Collapse
|